Precision has submitted multiple global clinical trial applications and is on track to submit additional CTA and IND filings as part of its global Phase 1 regulatory strategy for PBGENE-HBV.

The trial, funded by NIH's National Cancer Institute, aims to accelerate the discovery of more tailored treatments for these aggressive cancers of the blood and bone marrow. Full story ...

NCI’s groundbreaking precision medicine clinical trial, which showed that people with advanced cancer may benefit from genomic sequencing to help plan their treatment. “When President Biden and the ...

The precision medicine trial aims to match patients to treatments ... "When President Biden and the First Lady re-ignited the Cancer Moonshot, they set two clear goals: To prevent more than ...

BETHESDA, Md., Oct. 23, 2024 /PRNewswire/ -- The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting ...

Oct. 23, 2024 /PRNewswire/ -- The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test ... Cancer Moonshot, they set two clear goals ...

The fit and feel of contact lenses are very nuanced, and it can take some trial and error to make sure they’re just right. You want lenses that offer precise vision ...

Australian researchers are about to launch a human trial to treat spinal cord injury by transplanting cells from the noses of paralysed patients into the damaged area. Griffith University ...

Seven years after two teens were brutally killed near a wooded creek in Delphi, Indiana, the trial for the man accused in their deaths is officially underway. Police say Richard Allen is ...

Seven years after two teens were brutally killed near a wooded creek in Delphi, Indiana, the trial for the man accused in their deaths is officially underway. Police say Richard Allen is responsible ...

The fit was complete with some pink heels ... are currently undefeated in their season and the Bulldogs are currently at 5-1. The game marks a big showdown between new and old SEC blood.